Glycolipid-mediated basophil activation in alpha-gal allergy - 05/08/20
Doi : 10.1016/j.jaci.2020.02.006
Onyinye I. Iweala, MD, PhD a, b 
, Shailesh K. Choudhary, PhD a, Claire T. Addison a, Cole J. Batty, BS c, Camille M. Kapita, MS a, Claire Amelio, RN, BSN a, Alexander J. Schuyler, BS, BA d, Shenglou Deng, PhD e, Eric M. Bachelder, PhD c, Kristy M. Ainslie, PhD c, Paul B. Savage, PhD e, Patrick J. Brennan, MD, PhD f, Scott P. Commins, MD, PhD a, b
, Shailesh K. Choudhary, PhD a, Claire T. Addison a, Cole J. Batty, BS c, Camille M. Kapita, MS a, Claire Amelio, RN, BSN a, Alexander J. Schuyler, BS, BA d, Shenglou Deng, PhD e, Eric M. Bachelder, PhD c, Kristy M. Ainslie, PhD c, Paul B. Savage, PhD e, Patrick J. Brennan, MD, PhD f, Scott P. Commins, MD, PhD a, b a Department of Medicine, Thurston Arthritis Research Center, Division of Rheumatology, Allergy, and Immunology, Chapel Hill, NC
b Department of Pediatrics, University of North Carolina Food Allergy Initiative, Division of Allergy, Immunology and Rheumatology, Chapel Hill, NC
c the Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular Pharmaceutics, The University of North Carolina at Chapel Hill, Chapel Hill, NC
d the Division of Allergy & Clinical Immunology, University of Virginia, Charlottesville, Va
e the Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah
f the Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass
| Supported by National Institutes of Health (NIH) (grants UM1AI30936 to the University of North Carolina [UNC] Food Allergy Initiative and R01AI135049). O. I. Iweala was supported by NIH grant T32AI007062 and a 2019 Thurston Arthritis Research Center Pilot Award. P. J. Brennan was supported by the NIH (grant K08AI102945) and generous support from the Goodfellow and Karol families. The UNC Flow Cytometry Core Facility is supported in part by the NIH (grant P30CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center). Research reported in this publication was supported in part by the North Carolina Biotech Center (institutional support grant 2017-IDG-1025) and by the NIH (grant 1UM2AI30836-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the letter. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 146 - N° 2
P. 450-452 - Agosto 2020 Ritorno al numero
Articolo precedente
- HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency
- Giulia Prunotto, Ugonna T. Offor, Sujith Samarasinghe, Robert Wynn, Ajay Vora, Ben Carpenter, Claire Gowdy, Kieran McHugh, Kevin P. Windebank, Attilio Maria Rovelli, Mary A. Slatter, Andrew R. Gennery, Paul Veys, Chris M. Bacon, Simon Bomken, Giovanna Lucchini
- Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa
- Florence Assan, Jeremy Gottlieb, Florence Tubach, Said Lebbah, Nicolas Guigue, Geoffroy Hickman, Emeline Pape, Marine Madrange, Emmanuel Delaporte, Boualem Sendid, François Aubin, Francis Derouin, Stéphane Bretagne, Pascal Richette, Asma Smahi, Emilie Sbidian, Hervé Bachelez
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?